Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-11

FDA Approved: RUFINAMIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic Rufinamide (ANDA 204993) for the treatment of seizures associated with Lennox-Gastaut syndrome, providing a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)